Posts tagged as: technical analyis back to homepage

CrowdGather Stock Chart Analysis Video CrowdGather Stock Chart Analysis Video(0)

The CrowdGather (OTCBB: CRWG) chart keeps producing 25 percent bounces off a solid support at 20 cents back up to a resistance at 25 cents. The pps continues to hold over the 200 day simple moving average and is looking towards the 50 dma at 27 cents. The indicators look to be trying to reverse course as the Relative Strength Index is now pushing through the 50 mark, indicating that momentum is entering a bullish mode. Static resistance is ahead at 30 cents. If tested, the climb off support could be indicating a reversal Read More

CrowdGather Stock Chart Analysis Video CrowdGather Stock Chart Analysis Video(0)

After a large run from 11 cents to 51 cents, the CrowdGather chart has been consolidating in a range bound channel. Support is in place at 28 and 27 cents with limited resistance if the pps can move through 36 cents, which offers a better than 20 percent upside just to that point. The MACD is ready to drop a bullish cross and key indicators of momentum, such as the Full Stochastics and the Relative Strength Index are signaling that upward pressure is at hand. The stock price is holding the 200 day simple moving average, a sign a strength in the chart with the 50 dma just ahead at 31 cents. The consolidation is getting Read More

CrowdGather Video Stock Chart Analysis CrowdGather Video Stock Chart Analysis(0)

The CrowdGather, Inc. (OTCBB:CRWG) chart moved through resistance at 12.5 cents yesterday. Volume was below average, but the MACD and RSI are showing strength to trend and momentum in the chart. Importantly, there is a strong positive divergence Read More

Bounce Play Potential:  Hyperdynamics (HDY) Bounce Play Potential: Hyperdynamics (HDY)(0)

For those who love the bottom plays, Hyperdynamics Corp. (NYSE: HDY) is hitting the watchlist for today. The chart is oversold and has lost a good portion of its value recently. Only the most brief of fundamental due diligence has been performed, the chart has only been assessed for a potential technical correction. Read More

Stay Informed

Receive the OTCS Newsletter *


* required

Dana-Farber to Host Cellceutix Trials

Cellceutix Corporation (CTIX)
Cellceutix Corporation has filed its Investigational New Drug application with the FDA. Dana-Farber and Beth Israel Deaconess Medical Center will be hosting the clinical trials for Kevetrin, Cellceutix's novel cancer drug. Read more news and get a stock quote.

Diabetes Rate Growing Exponentially

According to the International Diabetes Federation, more than 500 million people will be diagnosed with diabetes in the next two decades, a more than 50 percent increase from today. Technologies are available presently to help manage the frequency, complications and costs associated with diabetes. Read the complete article to learn more.

Contacts and information

Have an opinion or news that you want to share?

Social networks

Most popular categories

© 2011 Viper Enterprises, LLC. All rights reserved.